Patents by Inventor David A. Rosenthal

David A. Rosenthal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12187797
    Abstract: Provided herein are antibodies that bind signal regulatory protein gamma (SIRP?), as well as SIRP? and/or SIRP?1, and methods of using such antibodies (referred to as SIRP antibodies). In some embodiments, the SIRP antibodies are human monoclonal antibodies that bind human SIRP? as well as SIRP? and/or SIRP?1. In some embodiments, the SIRP antibodies provided herein are useful for treating a disease or condition associated with overactivation and/or hyperproliferation of lymphocytes, myeloid cells, or a combination thereof, or a disease or condition associated with SIRP?, SIRP?1 and/or SIRP? activity.
    Type: Grant
    Filed: February 28, 2024
    Date of Patent: January 7, 2025
    Assignee: Electra Therapeutics, Inc.
    Inventors: Sandip Panicker, Adam David Rosenthal, Eileen Lingshu Rose
  • Publication number: 20240425613
    Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting.
    Type: Application
    Filed: August 27, 2024
    Publication date: December 26, 2024
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Tony Sang Young BYUN, Quehuong Thi DONG
  • Publication number: 20240400677
    Abstract: Provided herein are antibodies that bind signal regulatory protein SIRP? and methods of making and using such antibodies. In some embodiments, the antibodies comprise an Fc, and are useful for preferential depletion of certain SIRP? expressing cells. In some embodiments, the antibodies provided herein are useful for treating a disease or condition associated with the dysregulation of cells (e.g. overactivation or aberrant proliferation of T-cells).
    Type: Application
    Filed: May 9, 2024
    Publication date: December 5, 2024
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Eileen Lingshu ROSE, Allen Guo Yang CAI
  • Patent number: 12145999
    Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting.
    Type: Grant
    Filed: November 10, 2023
    Date of Patent: November 19, 2024
    Assignee: Vega Therapeutics, Inc.
    Inventors: Sandip Panicker, Adam David Rosenthal, Tony Sang Young Byun
  • Publication number: 20240285464
    Abstract: Quadrantanopial occlusive lenses and method of use includes the steps of performing a vision zone assessment test to identify a field area of a patient's field of view having a selected characteristic, based on the identified field area, providing an appliance having a non-transparent optical characteristic associated with the field area, the patient wearing the appliance, and while the patient is wearing the appliance, the patient performing a selected activity associated with the neurological performance. The neurological performance may be associated with the quality of performance of the selected activity. The selected activity may be a physical activity. The step of performing a vision zone assessment test may include moving a visual target about the patient's field of view. The step of performing a vision zone assessment test may include observing the patient's eye movements in response to a moving visual stimulus.
    Type: Application
    Filed: May 6, 2024
    Publication date: August 29, 2024
    Applicant: Rosenthal Holdings, LLC
    Inventor: David Rosenthal
  • Patent number: 12070338
    Abstract: Embodiments of the present disclosure generally relate to methods for analyzing outcomes of illnesses, such as COVID-19, on living organisms. More particularly, embodiments of the present disclosure relate to methods for identifying risk of illness based on genetic markers and other available data, predicting results of mass exposure to an Illness based on a populations genomes and other available data, and providing indicators and methods of visualization for probability of illness in any living organism.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 27, 2024
    Assignee: GENERAL GENOMICS, INC.
    Inventors: Daniel Alan Brue, Warren Dennis Gieck, Aronjol David Rosenthal
  • Publication number: 20240239888
    Abstract: Provided herein are antibodies that bind signal regulatory protein gamma (SIRP?), as well as SIRP? and/or SIRP?1, and methods of using such antibodies (referred to as SIRP antibodies). In some embodiments, the SIRP antibodies are human monoclonal antibodies that bind human SIRP? as well as SIRP? and/or SIRP?1. In some embodiments, the SIRP antibodies provided herein are useful for treating a disease or condition associated with overactivation and/or hyperproliferation of lymphocytes, myeloid cells, or a combination thereof, or a disease or condition associated with SIRP?, SIRP?1 and/or SIRP? activity.
    Type: Application
    Filed: February 28, 2024
    Publication date: July 18, 2024
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Eileen Lingshu ROSE
  • Publication number: 20240084038
    Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting.
    Type: Application
    Filed: November 10, 2023
    Publication date: March 14, 2024
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Tony Sang Young BYUN, Quehuong Thi DONG
  • Patent number: 11874126
    Abstract: A method includes obtaining a rule that is associated with a segment of a map, determining a state for use in evaluation of the rule, evaluating the rule using the state, identifying an action to be performed based on a result of evaluating the rule using the state, and utilizing the action to be performed as an input to an automated control system of a vehicle.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: January 16, 2024
    Assignee: APPLE INC.
    Inventors: David A. Rosenthal, Andreas H. Bockert, Jessica A. Butorac, Gunnar Martin Byrod, Shane T. Hinerman, Kjell Fredrik Larsson, William W. Luciw, Patrick L. Wheeler
  • Publication number: 20230303685
    Abstract: Provided herein are antibodies that bind signal regulatory protein gamma (SIRPy), as well as SIRP? and/or SIRP?1, and methods of using such antibodies (referred to as SIRP antibodies). In some embodiments, the SIRP antibodies are human monoclonal antibodies that bind human SIRPy as well as SIRP? and/or SIRP?1. In some embodiments, the SIRP antibodies provided herein are useful for treating a disease or condition associated with overactivation and/or hyperproliferation of lymphocytes, myeloid cells, or a combination thereof, or a disease or condition associated with SIRP?, SIRP?1 and/or SIRPy activity.
    Type: Application
    Filed: May 10, 2021
    Publication date: September 28, 2023
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Eileen Lingshu ROSE
  • Publication number: 20230258957
    Abstract: A kit of eyewear that comprises a plurality of eyewear elements, each having a frame and a lens associated with each eye. Each of the eyewear elements have an occluded portion of at least one lens; at least some of the eyewear elements having different occlusion areas on the left and right lenses; and the eyewear elements having different occlusions patterns from each other.
    Type: Application
    Filed: February 14, 2023
    Publication date: August 17, 2023
    Inventor: David Rosenthal
  • Publication number: 20230174672
    Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting, e.g. by depleting the circulating levels of TFPI, by disrupting a Protein S-TFPI complex, and/or by preventing the formation of a Protein S-TFPI complex.
    Type: Application
    Filed: May 5, 2021
    Publication date: June 8, 2023
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Tony Sang Young BYUN, Quehuong Thi DONG
  • Publication number: 20230174648
    Abstract: Provided herein are antibodies that bind signal regulatory protein SIRPa, SIRPß1, or a combination of SIRPa and SIRP?1, and methods of using such antibodies. In some embodiments, the antibodies are human monoclonal antibodies that bind human SIRPa and/or SIRP?1. In some embodiments, the antibodies provided herein are useful for treating a disease or condition associated with overactivation and/or hyperproliferation of myeloid cells, or a disease or condition associated with SIRPa and/or SIRP?1 activity.
    Type: Application
    Filed: May 10, 2021
    Publication date: June 8, 2023
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Eileen Lingshu ROSE
  • Publication number: 20230083243
    Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting.
    Type: Application
    Filed: May 5, 2021
    Publication date: March 16, 2023
    Inventors: Sandip PANICKER, Adam David ROSENTHAL, Tony Sang Young BYUN, Quehuong Thi DONG
  • Publication number: 20220020503
    Abstract: Embodiments of the present disclosure generally relate to methods for analyzing the effectiveness of preventative measures on the spread of illnesses, such as COVID-19, on living organisms. More particularly, embodiments of the present disclosure relate to methods for identifying the effectiveness of preventative measures, processes, equipment and other available data, and providing indicators and methods of visualization the effectiveness of preventative measures on the spread of an illness.
    Type: Application
    Filed: March 19, 2021
    Publication date: January 20, 2022
    Inventors: Warren Dennis GIECK, Aronjol David ROSENTHAL
  • Publication number: 20210313067
    Abstract: Embodiments of the present disclosure generally relate to methods for analyzing survivability of illnesses, such as COVID-19. More particularly, embodiments of the present disclosure relate to methods for identifying correlations and influencing factors between genetic markers, lifestyle, and other available data that lead to predictions of the effectiveness of medical treatments, predicting results of mass exposure to an illness based on a population's genomes and other available data, and providing indicators and methods of visualization for survivability of a viral infection or cancer in any living organism.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 7, 2021
    Inventors: Daniel Alan BRUE, Warren Dennis GIECK, Aronjol David ROSENTHAL
  • Publication number: 20210307700
    Abstract: Embodiments of the present disclosure generally relate to methods for analyzing outcomes of illnesses, such as COVID-19, on living organisms. More particularly, embodiments of the present disclosure relate to methods for identifying risk of illness based on genetic markers and other available data, predicting results of mass exposure to an Illness based on a populations genomes and other available data, and providing indicators and methods of visualization for probability of illness in any living organism.
    Type: Application
    Filed: March 19, 2021
    Publication date: October 7, 2021
    Inventors: Daniel Alan BRUE, Warren Dennis GIECK, Aronjol David ROSENTHAL
  • Publication number: 20210313068
    Abstract: Embodiments of the present disclosure generally relate to methods for analyzing survivability of illnesses, such as COVID-19. More particularly, embodiments of the present disclosure relate to methods for identifying correlations and influencing factors between genetic markers, lifestyle, and other available data that lead to predictions of the effectiveness of medical treatments, predicting results of mass exposure to an illness based on a population's genomes and other available data, and providing indicators and methods of visualization for survivability of a viral infection or cancer in any living organism.
    Type: Application
    Filed: March 19, 2021
    Publication date: October 7, 2021
    Inventors: Daniel Alan BRUE, Warren Dennis GIECK, Aronjol David ROSENTHAL
  • Publication number: 20210307701
    Abstract: Embodiments of the present disclosure generally relate to methods for analyzing outcomes of illnesses, such as COVID-19, on living organisms. More particularly, embodiments of the present disclosure relate to methods for identifying risk of illness based on genetic markers and other available data, predicting results of mass exposure to an Illness based on a populations genomes and other available data, and providing indicators and methods of visualization for probability of illness in any living organism.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 7, 2021
    Inventors: Daniel Alan BRUE, Warren Dennis GIECK, Aronjol David ROSENTHAL
  • Patent number: 10700009
    Abstract: A method is provided for void-free Ru metal filling of features in a substrate. The method includes providing a substrate containing features, depositing a Ru metal layer in the features, removing the Ru metal layer from a field area around an opening of the features, and depositing additional Ru metal in the features, where the additional Ru metal is deposited in the features at a higher rate than on the field area. According to one embodiment, the additional Ru metal is deposited until the features are fully filled with Ru metal.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: June 30, 2020
    Assignee: Tokyo Electron Limited
    Inventors: Kai-Hung Yu, Nicholas Joy, Eric Chih Fang Liu, David L. O'Meara, David Rosenthal, Masanobu Igeta, Cory Wajda, Gerrit J. Leusink